Jazz Pharmaceuticals (JAZZ) Tops Q2 EPS by 10c; Guides In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 207.83 +2.77 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $205.06 | 52 Week High | $160.00 | |||
| Open | $207.00 | 52 Week Low | $95.80 | |||
| Day High | $211.32 | P/E | 38.63 | |||
| Day Low | $205.73 | EPS | $5.38 | |||
| Volume | 773,584 | |||||
